Ketamine improves survival in burn injury followed by sepsis in rats

Anesthesia and Analgesia

Volumn 103, Issue 2, 2006, Pages 396-402

  Gurfinkel, Reuven ^a   Czeiger, David ^a   Douvdevani, Amos ^a   Shapira, Yoram ^a   Artru, Alan A ^b   Sufaro, Yuval ^a   Mazar, Julia ^a   Shaked, Gad ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; KETAMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MARKER; ESCHERICHIA COLI; INFLAMMATION; INOCULATION; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 33746513957     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000226140.84281.3e     Document Type: Article

References (25)

1. Schwacha MG, Chung CS, Ayala A, et al. Cyclooxygenase 2 mediated suppression of macrophage interleukin-12 production after thermal injury. Am J Physiol Cell Physiol 2002;282:C263-70.
2. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 1992;216:117-34.
3. Weigand MA, Schmidt H, Zhao Z, et al. Ketamine modulates the stimulated adhesion molecule expression on human neutrophils in vitro. Anesth Analg 2000;90:206-12.
4. Yu Y, Zhou Z, Xu J, et al. Ketamine reduces Nf-kappaB activation and TNF-alpha production in rat mononuclear cells induced by lipopolysaccharide in vitro. Ann Clin Lab Sci 2002;32:292-8.
5. Kawasaki T, Ogata M, Kawasaki C, et al. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg 1999;89:665-9.
6. Shaked G, Czeiger D, Dukhno O, et al. Ketamine improves survival and suppresses IL-6 and TNF-alpha production in a model of Gram-negative bacterial sepsis in rats. Resuscitation 2004;62:237-42.
7. Heller A, Heller S, Blecken S, et al. Effects of intravenous anesthetics on bacterial elimination in human blood in vitro. Acta Anaesthesiol Scand 1998;42:518-26.
8. Mazar J, Rogachev B, Shaked G, et al. Involvement of adenosine in the anti-inflammatory action of ketamine. Anesthesiology 2005;102:1174-81.
9. Blackwell TS, Christman JW. Sepsis and cytokines: current status. Br J Anaesth 1996;77:110-7.
10. Meyer TN, daSilva AL. Ketamine reduces mortality of severely burnt rats, when compared to midazolam plus fentanyl. Burns 2004;30:425-30.
11. Taniguchi T, Shibata K, Yamamoto K. Ketamine inhibits endotoxin-induced shock in rats. Anesthesiology 2001;95:928-32.
12. Busund R, Balteskard L, Ronning G, et al. Fatal myocardial depression and circulatory collapse associated with complement activation induced by plasma infusion in severe porcine sepsis. Acta Anaesthesiol Scan 1995;39:100-8.
13. Modig J. Positive effects of ketamine v. metomidate anesthesia on cardiovascular function, oxygen delivery and survival: studies with a porcine endotoxin model. Acta Chir Scand 1987;153:7-13.
14. Worek FS, Blumel G, Zeravik J, et al. Comparison of ketamine and pentobarbital anesthesia with the conscious state in a porcine model of Pseudomonas aeruginosa septicemia. Acta Anaesthesiol Scand 1988;32:509-15.
15. Schwacha MG, Chaudry IH. The cellular basis of post-burn immunosuppression: macrophages and mediators. Int J Mol Med 2002;10:239-43.
16. Gosain A, Gamelli RL. Role of the gastrointestinal tract in burn sepsis. J Burn Care Rehabil 2005;26:85-91.
17. Klein D, Einspanier R, Bolder U, Jeschke MG. Differences in the hepatic signal transcription pathway and cytokine expression between thermal injury and sepsis. Shock 2003;20:536-43.
18. Kalkoff M, Cursons RT, Sleigh JW, Jacobson GM. The use of real time rtPCR to quantify inflammatory mediator expression in leukocytes from patients with severe sepsis. Anaesth Intensive Care 2004;32:746-55.
19. Ogle CK, Kong F, Guo X, et al. The effect of burn injury on suppressors of cytokine signaling. Shock 2000;14:392-8.
20. Kinoshita M, Seki S, Ono S, et al. Paradoxical effect of IL-18 therapy on the severe and mild Escherichia coli infections in burn-injured mice. Ann Surg 2004;240:313-20.
21. Helmer KS, Cui Y, Dewan A, Mercer D. Ketamine/xylazine attenuates LPS-induced iNOS expression in various rat tissues. J Surg Res 2003;112:70-8.
22. Helmer KS, Cui Y, Chang L, et al. Effects of ketamine/xylazine on expression of tumor necrosis factor-alpha, inducible nitric oxide synthase, and cyclo-oxygenase-2 in rat gastric mucosa during endotoxemia. Shock 2003;20:63-9.
23. Chen RM, Chen TL, Lin YL, et al. Ketamine reduces nitric oxide biosynthesis in human umbilical vein endothelial cells by down-regulating endothelial nitric oxide synthase expression and intracellular calcium levels. Crit Care Med 2005;33:1162-3.
24. Keilhoff G, Becker A, Grecksch G, et al. Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience 2004;126:591-8.
25. Bulutcu F, Dogrul A, Guc MO. The involvement of nitric oxide in the analgesic effects of ketamine. Life Sci 2002;71:841-53.